12:00 AM
 | 
Jun 24, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Raptor sales and marketing update

Raptor launched Procysbi cysteamine bitartrate in the U.S. to treat nephropathic cystinosis in patients six years of...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >